Efficacy of natural killer cell therapy combined with chemoradiotherapy in murine models of head and neck squamous cell carcinoma

• Published in: Cytotherapy (Oxford, England) Vol. 26; no. 3; pp. 242 - 251
• Main Authors: Jung, Eun Kyung, Chu, Tan-Huy, Kim, Sun-Ae, Vo, Manh-Cuong, Nguyen, Van-Tan, Lee, Kyung-Hwa, Jung, Sung-Hoon, Yoon, Meesun, Cho, Duck, Lee, Je-Jung, Yoon, Tae Mi
• Format: Journal Article
• Language: English
• Published: England Elsevier Inc 01.03.2024
• Subjects: animal model; Animals; Cell Line, Tumor; chemoradiation; Chemoradiotherapy; Disease Models, Animal; Head and Neck Neoplasms - metabolism; Head and Neck Neoplasms - therapy; head and neck squamous cell carcinoma; Humans; Killer Cells, Natural - metabolism; Mice; Mice, Inbred NOD; Mice, SCID; natural killer cells; NKG2D; Squamous Cell Carcinoma of Head and Neck - metabolism; Squamous Cell Carcinoma of Head and Neck - therapy; natural killer cells; NKG2D; animal model; chemoradiation; head and neck squamous cell carcinoma
• ISSN: 1465-3249; 1477-2566
• DOI: 10.1016/j.jcyt.2023.11.002

Natural killer (NK) cell-based cancer immunotherapy is effective when combined with other treatment modalities such as irradiation and chemotherapy. NK cell's antitumor function to treat solid tumor, including head and neck squamous cell carcinoma (HNSCC), has been targeted recently. This study assessed NK cell recruitment in response to chemoradiation therapy (CRT) in HNSCC. Ex vivo expansion of NK cell, flow cytometry, cell viability assay, cytotoxicity assay, immunohistochemistry, and animal model were performed. Mouse NK cells were recruited to the tumor site by CRT in a nude mouse model. Furthermore, expanded and activated human NK cells (eNKs) were recruited to the tumor site in response to CRT, and CRT enhanced the anti-tumor activity of eNK in an NOD/SCID IL-2Rγnull mouse model. Various HNSCC cancer cell lines exhibited different NK cell ligand activation patterns in response to CRT that correlated with NK cell-mediated cytotoxicity. Identifying the activation patterns of NK cell ligands during CRT might improve patient selection for adjuvant NK cell immunotherapy combined with CRT. This is the first study to investigate the NK cell's antitumor function and recruitment with CRT in HNSCC mouse model.